Obecabtagene autoleucel
Obecabtagene autoleucel is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including AUCATZYL. Available dosage form: kit.
Drug Details
- Generic Name
- Obecabtagene autoleucel
- Brand Names
- AUCATZYL
- Application Number
- BLA125813
- Sponsor
- Autolus Inc.
- NDC Codes
- 2
- Dosage Forms
- KIT
- Routes
- N/A
- Active Ingredients
- N/A
Indications and Usage
1 INDICATION AND USAGE AUCATZYL is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). AUCATZYL is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) ( 1 ).